Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …
W Jassat, C Cohen, S Tempia, M Masha… - The Lancet …, 2021 - thelancet.com
Background The interaction between COVID-19, non-communicable diseases, and chronic infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …
Background This study applies an umbrella review approach to summarise the global evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …
Objectives We conducted a systematic literature review and meta-analysis of observational studies to investigate the association between diabetes, hypertension, body mass index …
E Ge, Y Li, S Wu, E Candido, X Wei - PLoS One, 2021 - journals.plos.org
Background The novel coronavirus disease 2019 (COVID-19) has infected 1.9% of the world population by May 2, 2021. Since most previous studies that examined risk factors for …
Z Nikoloski, AM Alqunaibet, RA Alfawaz… - BMC Public Health, 2021 - Springer
Abstract Background Since early 2020, the Covid-19 pandemic has engulfed the world. Amidst the growing number of infections and deaths, there has been an emphasis of …
SM Hsieh, MC Liu, YH Chen, WS Lee… - The Lancet …, 2021 - thelancet.com
Background MVC-COV1901, a recombinant protein vaccine containing pre-fusion-stabilised spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide, has been shown to …
Since its emergence in December 2019, SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has taken a tremendous toll globally; by 28 February 2021, there …
N Saber‐Moghaddam, S Salari, S Hejazi… - Phytotherapy …, 2021 - Wiley Online Library
Curcumin is proposed as a potential treatment option for coronavirus disease‐19 (COVID‐ 19) by inhibiting the virus entrance, encapsulation and replication, and modulating various …